Blennow K

Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases.

Karlsson L, Vogel J, Arvidsson I, ..., Mattsson-Carlgren N, Hansson O

Nat Commun 15 (1) 3676 [2024-05-01; online 2024-05-01]

DDLS Fellow Jacob W Vogel

Biomarker-based staging of Alzheimer disease: rationale and clinical applications.

Therriault J, Schindler SE, Salvadó G, ..., Jack CR, Rosa-Neto P

Nat Rev Neurol 20 (4) 232-244 [2024-04-00; online 2024-03-01]

DDLS Fellow Jacob W Vogel

Spatial Neurolipidomics at the Single Amyloid-β Plaque Level in Postmortem Human Alzheimer's Disease Brain.

Michno W, Bowman A, Jha D, ..., Heeren RMA, Hanrieder J

ACS Chem Neurosci 15 (4) 877-888 [2024-02-21; online 2024-02-01]

SciLifeLab Fellow Wojciech Michno

Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias.

Michno W, Koutarapu S, Camacho R, ..., Lashley T, Hanrieder J

J. Neurochem. 163 (3) 233-246 [2022-11-00; online 2022-09-25]

SciLifeLab Fellow Wojciech Michno

Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.

Michno W, Stringer KM, Enzlein T, ..., Edwards FA, Hanrieder J

Sci Adv 7 (25) - [2021-06-00; online 2021-06-16]

SciLifeLab Fellow Wojciech Michno